Published in Aliment Pharmacol Ther on March 01, 2002
Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil (2012) 2.03
Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial. Dig Dis Sci (2015) 1.46
The association between prucalopride efficacy and constipation type. Tech Coloproctol (2013) 1.42
Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation. Dig Dis Sci (2010) 1.18
Pharmacology of serotonin: what a clinician should know. Gut (2004) 1.02
Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study. Br J Clin Pharmacol (2012) 0.95
Prucalopride: safety, efficacy and potential applications. Therap Adv Gastroenterol (2012) 0.94
Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation. J Neurogastroenterol Motil (2014) 0.88
Drug development for the irritable bowel syndrome: current challenges and future perspectives. Front Pharmacol (2013) 0.88
Prucalopride: the evidence for its use in the treatment of chronic constipation. Core Evid (2008) 0.87
Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized, Placebo-controlled Studies. J Neurogastroenterol Motil (2014) 0.84
Effect of enterokinetic prucalopride on intestinal motility in fast rats. World J Gastroenterol (2003) 0.84
Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol (2014) 0.80
Understanding and treating refractory constipation. World J Gastrointest Pharmacol Ther (2014) 0.79
Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation. Clin Exp Gastroenterol (2010) 0.78
Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists. J Neurogastroenterol Motil (2017) 0.75
Relamorelin to Treat Constipation: "Pusher" or Pushover? Dig Dis Sci (2016) 0.75
Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach. Drug Des Devel Ther (2016) 0.75
Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil (2012) 7.24
Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet (2000) 5.31
The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil (2014) 4.69
[Reduced risk of complications associated with severe acute (necrotizing) pancreatitis by administration of antibiotics; results from a literature review]. Ned Tijdschr Geneeskd (2001) 4.00
Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev (2006) 3.96
[Acute pancreatitis--a protocol for diagnosis and treatment]. Ned Tijdschr Geneeskd (2001) 3.91
High frequency of early colorectal cancer in inflammatory bowel disease. Gut (2008) 3.46
[Total mesorectal excision: a new standard for surgical treatment of rectal carcinoma]. Ned Tijdschr Geneeskd (1996) 2.68
Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care (2001) 2.60
[Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial]. Ned Tijdschr Geneeskd (2008) 2.52
[Ancillary diagnostic imaging is undesirable if there is evidence of appendicitis]. Ned Tijdschr Geneeskd (2007) 2.41
Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut (2010) 2.25
[Obtaining medical ethical approval for a multicentre, randomised study: prospective evaluation of a ponderous process]. Ned Tijdschr Geneeskd (2008) 2.21
Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2006) 2.07
Systematic review of percutaneous catheter drainage as primary treatment for necrotizing pancreatitis. Br J Surg (2011) 2.01
The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther (2013) 2.01
Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology (2000) 1.94
Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol (2011) 1.91
Temporary decompression after colorectal surgery: randomized comparison of loop ileostomy and loop colostomy. Br J Surg (1998) 1.88
Candidate genotypes associated with functional dyspepsia. Neurogastroenterol Motil (2008) 1.86
Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg (2010) 1.85
PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil (2012) 1.80
Gastric emptying in diabetes: clinical significance and treatment. Diabet Med (2002) 1.75
Determinants of perception of heartburn and regurgitation. Gut (2005) 1.69
The Atlanta Classification of acute pancreatitis revisited. Br J Surg (2008) 1.67
Prospective study of primary anastomosis following sigmoid resection for suspected acute complicated diverticular disease. Br J Surg (2001) 1.58
Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study. Am J Gastroenterol (2010) 1.58
Development of a test to measure gastric accommodation in humans. Am J Physiol (1999) 1.56
Quality of life and health status before and after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg (2011) 1.49
Gastrointestinal motility and gastric tube feeding in mechanically ventilated patients. Crit Care Med (1998) 1.49
Abdominal rectovaginopexy: modified technique to treat constipation. Dis Colon Rectum (1999) 1.47
Objective definition and detection of transient lower esophageal sphincter relaxation revisited: is there room for improvement? Neurogastroenterol Motil (2011) 1.46
Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut (2004) 1.43
[Surgical treatment of ulcerative colitis and familial adenomatous polyposis: recent developments]. Ned Tijdschr Geneeskd (1999) 1.43
Predictors of objectively identified recurrent reflux after primary Nissen fundoplication. Br J Surg (2011) 1.42
[Timing and choice of intervention in necrotising pancreatitis]. Ned Tijdschr Geneeskd (2005) 1.42
Functional results and visceral perception after ileo neo-rectal anastomosis in patients: a pilot study. Gut (2001) 1.40
[British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease]. Ned Tijdschr Geneeskd (2007) 1.40
[Pathophysiology and treatment of achalasia]. Ned Tijdschr Geneeskd (1996) 1.39
[Irritable bowel syndrome: pathophysiology and (future) treatment options]. Ned Tijdschr Geneeskd (2002) 1.39
The ileo neorectal anastomosis: an experimental study on development of the surgical technique and theoretical background. Colorectal Dis (2001) 1.39
[Therapy-resistant gastro-oesophageal reflux disease: endoluminal treatment not yet sufficiently compared with the gold standard, the laparoscopic Nissen fundoplication]. Ned Tijdschr Geneeskd (2008) 1.38
[Full clinical placements for medical students can start as early as the third year of medical training]. Ned Tijdschr Geneeskd (2007) 1.38
Gallbladder motility after duodenum-preserving resection of the head of the pancreas. Scand J Gastroenterol (1997) 1.38
[Treatment of severely delayed gastric emptying]. Ned Tijdschr Geneeskd (2000) 1.38
Quality of life with a temporary stoma: ileostomy vs. colostomy. Dis Colon Rectum (2000) 1.36
Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care (2003) 1.34
Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett (1998) 1.33
The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg (1998) 1.32
Responses to gastric distension in functional dyspepsia. Gut (1998) 1.32
Timing and impact of infections in acute pancreatitis. Br J Surg (2009) 1.32
Pitfalls in the analysis of electrogastrographic recordings. Gastroenterology (1999) 1.31
Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis. Cochrane Database Syst Rev (2009) 1.30
Pneumatosis cystoides intestinalis in intestinal pseudoobstruction. Resolution after therapy with metronidazole. Dig Dis Sci (1992) 1.29
Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut (2005) 1.29
Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut (2006) 1.28
Normal values for solid-state esophageal high-resolution manometry in a European population; an overview of all current metrics. Neurogastroenterol Motil (2014) 1.24
Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol (2001) 1.23
Rapidly increasing incidence of eosinophilic esophagitis in a large cohort. Neurogastroenterol Motil (2012) 1.22
Videoscopic assisted retroperitoneal debridement in infected necrotizing pancreatitis. HPB (Oxford) (2007) 1.17
Controversies in paraesophageal hernia repair: a review of literature. Surg Endosc (2005) 1.13
Staged multidisciplinary step-up management for necrotizing pancreatitis. Br J Surg (2013) 1.12
Surgical intervention in patients with necrotizing pancreatitis. Br J Surg (2006) 1.12
Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil (2003) 1.11
Long-term quality of life after surgery for chronic pancreatitis. Br J Surg (2010) 1.10
Coffee and gastrointestinal function: facts and fiction. A review. Scand J Gastroenterol Suppl (1999) 1.10
Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil (2008) 1.10
Laparoscopic versus small-incision cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev (2006) 1.09
Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.09
Fulminant acute pancreatitis and infected necrosis: results of open management of the abdomen and "planned" reoperations. J Am Coll Surg (1998) 1.09
Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy (2013) 1.09
Effect of different recumbent positions on postprandial gastroesophageal reflux in normal subjects. Am J Gastroenterol (2000) 1.07
Jaundice caused by hydatid disease of the liver. Neth J Med (1989) 1.07
Surgical management of acute necrotizing pancreatitis: a 13-year experience and a systematic review. Scand J Gastroenterol Suppl (2003) 1.07
Effect of intragastric barostat bag on proximal and distal gastric accommodation in response to liquid meal. Am J Physiol Gastrointest Liver Physiol (2002) 1.06
Assessment of oesophageal motor function using combined perfusion manometry and multi-channel intra-luminal impedance measurement in normal subjects. Neurogastroenterol Motil (2005) 1.05
Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. Gastroenterology (1994) 1.04
Reproducibility of esophageal high-resolution manometry. Neurogastroenterol Motil (2011) 1.04
Normal values for esophageal high-resolution manometry. Neurogastroenterol Motil (2013) 1.02
Systematic review: open, small-incision or laparoscopic cholecystectomy for symptomatic cholecystolithiasis. Aliment Pharmacol Ther (2008) 1.02
Impact of delayed gastric emptying on the outcome of antireflux surgery. Ann Surg (2001) 1.01
Stomach distension increases efferent muscle sympathetic nerve activity and blood pressure in healthy humans. J Neurol Sci (1998) 1.01
Elicitation of transient lower oesophageal sphincter relaxations in response to gastric distension and meal ingestion. Neurogastroenterol Motil (2002) 1.00
Fundal dysaccommodation in functional dyspepsia: head-to-head comparison between the barostat and three-dimensional ultrasonographic technique. Gut (2006) 1.00
The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther (2002) 0.99
Analysis and surgical treatment of persistent dysphagia after Nissen fundoplication. Br J Surg (2001) 0.99
Selection of patients with internal intussusception of the rectum for posterior rectopexy. Br J Surg (1990) 0.98
Double-peaked high-pressure zone at the esophagogastric junction in controls and in patients with a hiatal hernia: a study using high-resolution manometry. Dig Dis Sci (2004) 0.98